Wood Investment Counsel’s AbbVie ABBV Stock Holding History

Wood Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$246K	Buy	4,261 +500	+13%	+$27.8K	0.04%	75
2014 Q2	$212K	Buy	+3,761	New	+$197K	0.03%	77

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wood Investment Counsel's ABBV Position: Q3 2014 in Review

Wood Investment Counsel increased its AbbVie (ABBV) stake by 13% in Q3 2014, buying an estimated $27.8K and bringing the position to 4,261 shares worth $246K. The position accounts for 0.04% of the portfolio, ranked #75.

Wood Investment Counsel first reported a position in ABBV in Q2 2014 and has held it in 2 quarters since. 1,502 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

Wood Investment Counsel held 4,261 shares of AbbVie worth $246K as of Q3 2014.
Wood Investment Counsel bought 500 AbbVie shares in Q3 2014, an estimated $27.8K.
AbbVie made up 0.04% of Wood Investment Counsel's portfolio in Q3 2014, its #75 holding.
Wood Investment Counsel first reported a position in AbbVie in Q2 2014 and has held it in 2 quarters since.
1,502 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Wood Investment Counsel's 13F filing for Q3 2014, filed 27 Oct 2014.